|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 58.75 EUR | +0.17% |
|
-1.35% | -7.35% |
| 07-23 | Laboratorios Farmaceuticos Rovi, S.A., H1 2026 Earnings Call, Jul 23, 2026 | |
| 07-23 | Laboratorios Farmaceuticos Rovi, S.A. Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -2.39% | -6.36% | -7.62% | +16.40% | +4.34% | +47.10% | +149.66% | +338.05% | +1,255.61% | 1T | |
| -0.76% | -4.34% | -3.28% | +11.98% | +22.93% | +52.04% | +49.09% | +45.89% | +105.33% | 613B | |
| -2.33% | -4.60% | -6.12% | +18.64% | +7.27% | +25.55% | +64.44% | +110.84% | +268.18% | 433B | |
| +0.68% | -1.14% | +4.52% | +11.81% | +8.47% | +38.47% | +33.36% | +0.92% | +45.90% | 350B | |
| -1.66% | -3.13% | -2.67% | +7.42% | +13.59% | +32.18% | +39.79% | +49.14% | +55.62% | 292B | |
| -8.96% | -10.77% | -20.45% | -14.89% | -16.61% | +3.57% | +5.50% | +38.60% | +129.27% | 239B | |
| -1.37% | -7.41% | -7.53% | +8.74% | -7.06% | -2.10% | -43.67% | +3.69% | +64.92% | 206B | |
| -1.63% | +0.69% | +1.26% | +14.87% | +15.75% | +27.62% | +64.23% | +55.22% | +118.46% | 204B | |
| +0.72% | +0.48% | -0.09% | -0.38% | +6.85% | +15.88% | +73.64% | +87.81% | +63.75% | 163B | |
| +0.08% | +1.46% | +2.92% | -4.94% | +0.52% | +6.56% | -28.49% | -45.21% | -29.07% | 143B | |
| +0.24% | +4.65% | +12.63% | +12.45% | +21.38% | +48.02% | +6.92% | -5.54% | -12.47% | 134B | |
| -1.34% | -1.73% | -10.86% | +11.04% | +3.83% | +1.86% | +35.37% | +135.30% | +368.66% | 119B | |
| -1.14% | -2.63% | -5.24% | +0.45% | +4.66% | +36.73% | +41.93% | +6.57% | -8.66% | 103B | |
| +0.04% | -4.23% | -1.73% | -6.66% | -9.94% | -7.27% | -19.21% | -13.82% | +1.47% | 103B | |
| -0.73% | -5.19% | -12.00% | -18.02% | -19.50% | -9.13% | +61.19% | +66.52% | +443.93% | 70.18B | |
| -2.03% | -7.83% | -4.04% | -0.30% | +9.49% | +25.48% | +21.87% | +46.24% | +11.83% | 55.08B | |
| -1.94% | -0.23% | -11.69% | +23.84% | +27.32% | +67.57% | -8.66% | -5.97% | -50.07% | 53.26B | |
| -2.00% | -1.12% | -2.66% | -1.63% | -11.03% | -13.55% | +25.38% | -7.67% | +226.04% | 51.77B | |
| -0.28% | -2.13% | -0.55% | +5.29% | -3.34% | -0.85% | +11.49% | - | - | 42.85B | |
| Average | -0.98% | -2.55% | -3.96% | +5.06% | +4.16% | +20.83% | +30.73% | +50.37% | +169.93% | 230.26B | |
| Weighted average by Cap. | -0.79% | -3.62% | -4.44% | +9.40% | +6.89% | +31.04% | +59.12% | +110.61% | +375.31% |
- Stock Market
- Stocks
- ROVI Stock
- ROVI Stock
- Sector Laboratorios Farmaceuticos Rovi, S.A.
Select your edition
All financial news and data tailored to specific country editions
